X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Foot and Ankle Surgery

期刊標題檢索 FOOT ANKLE SURG 最新評論: How did it go in the end? (2022-12-17)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Foot and Ankle Surgery]您好,您是該頁面的第 13306 位訪客。

期刊簡介
期刊名稱Foot and Ankle Surgery Foot and Ankle Surgery
LetPub Score
5.3
50 ratings
Rate

Reputation
6.3

Influence
3.7

Speed
9.2

期刊簡稱FOOT ANKLE SURG
ISSN1268-7731
E-ISSN1460-9584
h-index32
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.600.9421.303
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Orthopedics and Sports Medicine
Q281 / 321

自引率 (2023-2024)10.50%自引率趨勢
掲載範囲
Foot and Ankle Surgery is essential reading for everyone interested in the foot and ankle and its disorders. The approach is broad and includes all aspects of the subject from basic science to clinical management. Problems of both children and adults are included, as is trauma and chronic disease. Foot and Ankle Surgery is the official journal of European Foot and Ankle Society.

The aims of this journal are to promote the art and science of ankle and foot surgery, to publish peer-reviewed research articles, to provide regular reviews by acknowledged experts on common problems, and to provide a forum for discussion with letters to the Editors. Reviews of books are also published. Papers are invited for possible publication in Foot and Ankle Surgery on the understanding that the material has not been published elsewhere or accepted for publication in another journal and does not infringe prior copyright.
官方網站http://www.footanklesurgery-journal.com/
在線稿件提交https://www.editorialmanager.com/FAS
開放訪問No
出版商Elsevier Ltd
主題領域ORTHOPEDICS
出版國/地區ENGLAND
發行頻率
創刊年0
每年文章數104每年文章數趨勢
黃金OA百分比14.65%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ORTHOPEDICSSCIEQ255/136
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1268-7731%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Foot and Ankle Surgery】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE645729
    BIOMATERIALS601395
    Frontiers in Pharmacology504146
    BIOMEDICINE & PHARMACOTHERAPY498664
    JOURNAL OF ETHNOPHARMACOLOGY496698
    Journal of Materials Chemistry B476183
    Frontiers in Immunology461437
    COMPUTERS IN BIOLOGY AND MEDICINE420844
    COLLOIDS AND SURFACES B-BIOINTERFACES419556
    Frontiers in Oncology415897
  •  

    Foot and Ankle Surgery Foot and Ankle Surgery
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Foot and Ankle Surgery] 的評論撰寫評論
作者: Yale Bush


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-17 20:46:15 評論於
How did it go in the end?
(0) 讚! | Yale Bush

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 19:35:30 評論於
We suggest dividing discussions on research limitations into three parts: (1) presenting research limitations; (2) explaining research limitations in detail; and (3) proposing future research directions or improvement plans. By discussing research limitations in this order, you can clearly present the shortcomings of the research without compromising its quality and validity
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 18:42:38 評論於
It is still necessary for us to clearly explain the limitations of the research in the paper, and to explain the impact of these limitations on the conclusions of the paper, so that reviewers and other readers can understand that we have fully considered the limitations of the study. In general, discussing the limitations of the research in the discussion section makes the article more credible. Thinking about how to overcome these limitations in future research will have a positive effect
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 12:14:08 評論於
How to address limitations in a discussion?
(0) 讚! | 八坂篷蔚

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 11:57:09 評論於
Is it necessary to mention the limitations of the article in the discussion?
(0) 讚! | 北国博达

作者: sunkaiortholivea


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2018-09-22 22:55:32 評論於
Received review comments one month after submission. Took two days to revise the paper and resubmit. Now waiting for the review results. The journal is good.

(0) 讚! | sunkaiortholivea

作者: 西风傲菡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-09-21 13:32:36 評論於
Review speed: 2.0 Experience sharing: After submitting for a month and revising it, it was revised in two days and resubmitted. Now waiting for news. The magazine feels pretty good
(0) 讚! | 西风傲菡

作者: 五轮耀兴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-08-24 16:16:22 評論於
Orthopedic journals are like this, even if you aim for the top ones, the difference is not much higher, it's easier to submit to lower-ranked ones
(0) 讚! | 五轮耀兴

作者: akm


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2018-08-24 14:00:08 評論於
As with the orthopedic journals, the highest scores are not much higher. It is easier to submitted more low scores.
(0) 讚! | akm

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Foot and Ankle Surgery] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*